Related Experiment Videos
One dose cefuroxime prophylaxis in hip fracture surgery
J P Kaukonen1, E Kemppainen, J Mäkijärvi
1Department of Surgery, Päijät-Häme Central Hos2pital, Lahti, Finland.
Annales Chirurgiae Et Gynaecologiae
|January 1, 1995
Summary
This study investigated cefuroxime antibiotic prophylaxis for hip fracture surgery. Results showed no significant difference in infection rates between the prophylaxis and control groups, suggesting limited impact.
Area of Science:
- Orthopedic Surgery
- Infectious Disease Prevention
- Pharmacology
Background:
- Surgical site infections (SSIs) are a significant complication in orthopedic procedures.
- Antibiotic prophylaxis is standard practice to reduce SSI risk.
- Cefuroxime is a commonly used antibiotic for surgical prophylaxis.
Purpose of the Study:
- To evaluate the efficacy of a single intravenous dose of cefuroxime in preventing infections following hip fracture surgery.
- To compare infection rates in patients receiving cefuroxime prophylaxis versus a control group.
Main Methods:
- A randomized trial involving 162 consecutive hip fracture patients.
- Administration of a 3g intravenous dose of cefuroxime during anesthesia induction in the prophylaxis group.
- Monitoring and comparison of overall and deep infection rates between groups.
Main Results:
- The overall infection rate was 8.0% (7 infections in prophylaxis vs. 6 in control).
- The deep infection rate was 3.9% in the prophylaxis group and 1.4% in the control group.
- No statistically significant difference in infection rates was observed between the groups.
Conclusions:
- A single intravenous dose of cefuroxime administered during anesthesia induction did not significantly reduce infection rates in hip fracture surgery.
- Further research may be needed to determine optimal antibiotic prophylaxis strategies for this patient population.